Anne-Marie C Dingemans

sysselsättning: forskare

Serier

Det finns ingenting här

Skapa en ny serie

Verk

Det finns ingenting här

Skapa ett nytt verk

Artiklar 18

Datum

Titel

Författare

2016-12-21

PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer

Ronald Boellaard, Dirk De Ruysscher, Wouter van Elmpt, Michel C Öllers, Judith van Loon, Anne-Marie C Dingemans, Hugo J.W.L. Aerts, Aniek J G Even, Frank Hoebers, Ludwig Dubois, Boudewijn Brans, Danielle J. Vugts
2016-11-21

Is selective nodal irradiation in non-small cell lung cancer still safe when using IMRT? Results of a prospective cohort study.

Dirk De Ruysscher, Angela van Baardwijk, Ruud M A Houben, Esther G. Troost, Michel C Öllers, Anne-Marie C Dingemans, Rinus Wanders, Bart Reymen
2014-05-17

A prospective study comparing the predictions of doctors versus models for treatment outcome of lung cancer patients: a step toward individualized care and shared decision making

Dirk De Ruysscher, Angela van Baardwijk, Georgi Nalbantov, Cary Oberije, Anne-Marie C Dingemans, Rinus Wanders, Jacques Borger, Liesbeth J Boersma, Bart Reymen
2014-01-17

Long-term survival of stage T4N0-1 and single station IIIA-N2 NSCLC patients treated with definitive chemo-radiotherapy using individualised isotoxic accelerated radiotherapy (INDAR).

Dirk De Ruysscher, Angela van Baardwijk, Anne-Marie C Dingemans, Rinus Wanders, Jacques Borger, Bart Reymen, Cordula Pitz, Ragnar Lunde, Wiel Geraedts
2013-09-14

Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patients

Esther G. Troost, Andre Dekker, Dirk De Ruysscher, Angela van Baardwijk, Johan Bussink, Georgi Nalbantov, Cary Oberije, Anne-Marie C Dingemans
2012-08-09

Response assessment using 18F-FDG PET early in the course of radiotherapy correlates with survival in advanced-stage non-small cell lung cancer

Dirk De Ruysscher, Wouter van Elmpt, Michel C Ollers, Anne-Marie C Dingemans
2012-11-29

Total gross tumor volume is an independent prognostic factor in patients treated with selective nodal irradiation for stage I to III small cell lung cancer

Dirk De Ruysscher, Angela van Baardwijk, Anne-Marie C Dingemans, Rinus Wanders, Jacques Borger, Bart Reymen, Cordula Pitz, Ragnar Lunde, Wiel Geraedts
2012-10-01

Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450).

Dirk De Ruysscher, Angela van Baardwijk, Ruud M A Houben, Anne-Marie C Dingemans, Rinus Wanders, Bart Reymen, Cordula Pitz, Wiel Geraedts, Brigitta G Baumert
2012-05-18

Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer.

Dirk De Ruysscher, Angela van Baardwijk, Michel C Ollers, Anne-Marie C Dingemans, Jacques Borger, Stofferinus Wanders, Bart Reymen, Cordula Pitz, Ragnar Lunde, Wiel Geraedts
2011-05-14

Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study

Dirk De Ruysscher, Wouter van Elmpt, Michel C Ollers, Judith van Loon, Anne-Marie C Dingemans
2011-07-04

Treatment with curative intent of stage III non-small cell lung cancer patients of 75 years: a prospective population-based study

Dirk De Ruysscher, Angela van Baardwijk, Anne-Marie C Dingemans, Rinus Wanders, Jacques Borger, Jessie Steevens, Anita Botterweck, Bart Reymen, Cordula Pitz, Ragnar Lunde, Wiel Geraedts
2011-11-17

Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: a prospective population-based study.

Andre Dekker, Dirk De Ruysscher, Angela van Baardwijk, Anne-Marie C Dingemans, Geert Bosmans, Rinus Wanders, Jacques Borger, Michel Oellers, Jessie Steevens, Anita Botterweck, Bart Reymen, Cordula Pitz, Ragnar Lunde, Wiel Geraedts
2010-05-01

Sorafenib in patients with advanced non-small cell lung cancer that harbor K-ras mutations: a brief report

Erik Thunnissen, Pieter E Postmus, Egbert F Smit, Anne-Marie C Dingemans, Robert-Jan van Suylen
2010-04-15

A multicenter phase II study of erlotinib and sorafenib in chemotherapy-naive patients with advanced non-small cell lung cancer

Erik Thunnissen, Elisa Giovannetti, Pieter E Postmus, Daniëlle A M Heideman, Egbert F Smit, Anne-Marie C Dingemans, Robert-Jan van Suylen, Joline S W Lind
2010-09-29

[¹⁸F]fluorodeoxyglucose uptake patterns in lung before radiotherapy identify areas more susceptible to radiation-induced lung toxicity in non-small-cell lung cancer patients.

Andre Dekker, Dirk De Ruysscher, Cary Oberije, Anne-Marie C Dingemans, Steven F Petit, Wouter van Elmpt
2009-02-03

Increased (18)F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent Radiation-Induced Lung Toxicity (RILT): a prospective pilot study

Andre Dekker, Dirk De Ruysscher, Michel C Ollers, Anne-Marie C Dingemans, Rinus Wanders, Jacques Borger, Monique Hochstenbag, Liesbeth J Boersma, Hugo J.W.L. Aerts, Cary Dehing
2008-03-14

18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study

Andre Dekker, Dirk De Ruysscher, Angela van Baardwijk, Ruud M A Houben, Anne-Marie C Dingemans, Judith van Loon, Geert Bosmans, Rinus Wanders, Jacques Borger, Michel Oellers, Jaap Teule, Gabriel Snoep, Monique Hochstenbag
2008-08

Individualized Radical Radiotherapy of Non–Small-Cell Lung Cancer Based on Normal Tissue Dose Constraints: A Feasibility Study

Dirk De Ruysscher, Angela van Baardwijk, Anne-Marie C Dingemans, Geert Bosmans, Stofferinus Wanders, Liesbeth J Boersma, Cordula Pitz, Wiel Geraedts

Människa - wd:Q114339985

Välkommen till Inventaire

din gemenskap och vänners bibliotek

lär mer